cyclopentane has been researched along with Pain in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (70.59) | 29.6817 |
| 2010's | 5 (29.41) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dolan, S; Goldie, M | 1 |
| Ao, GZ; Fan, JH; Gao, XM; Gu, WW; Ishidoh, K; Nobuhiko, K; Sun, SC; Zhang, HL; Zhou, Q; Zhu, YM | 1 |
| Beitz, AJ; Han, HJ; Kim, HW; Kim, KW; Kwon, YB; Lee, JH; Roh, DH; Seo, HS; Yoon, SY | 2 |
| Chen, SR; Pan, HL; Samoriski, G | 1 |
| Olugbemide, AS; Umukoro, S | 1 |
| Dina, OA; Fernández-Ballester, G; Ferrer-Montiel, A; Goswami, C; Hucho, T; Kuhn, J; Levine, JD | 1 |
| Kanai, T; Maruta, T; Nemoto, T; Satoh, S; Tsuneyoshi, I; Wada, A; Yanagita, T | 1 |
| Fisher, MH; Garcia, ML; Kaczorowski, GJ; Li, C; Lyons, KA; Martin, WJ; Meinke, PT; Ok, D; Parsons, WH; Priest, BT; Shao, PP; Smith, MM; Wyvratt, MJ; Ye, F | 1 |
| Atkinson, S; Brown, SH; Chessell, IP; Chowdhury, A; Clayton, NM; Coleman, T; Giblin, GM; Gleave, RJ; Hall, A; Hammond, B; Healy, MP; Johnson, MR; Michel, AD; Naylor, A; Novelli, R; Spalding, DJ; Tang, SP | 1 |
| Bit, RA; Brown, SH; Chaignot, HM; Chessell, IP; Chowdhury, A; Clayton, NM; Coleman, T; Giblin, GM; Hall, A; Hammond, B; Hurst, DN; Michel, AD; Naylor, A; Novelli, R; Scoccitti, T; Spalding, D; Tang, SP; Wilson, AW; Wilson, R | 1 |
| Althaus, M; Hanschmann, A; Klein, T; Magerl, W; Treede, RD | 1 |
| Ilyin, VI; Kyle, DJ | 1 |
| Bland, JS; Carroll, B; Darland, G; Hall, A; Katke, J; Lamb, J; Lerman, RH; Minich, DM; Tripp, M | 1 |
| Carlton, SM; Du, J; Zhou, S | 1 |
| Headley, MP; Houghton, AK; Parsons, CG | 1 |
2 review(s) available for cyclopentane and Pain
| Article | Year |
|---|---|
Sodium channel blockers.
Topics: Analgesics; Anesthetics, Local; Animals; Anti-Arrhythmia Agents; Anticonvulsants; Benzyl Compounds; Cyclopentanes; Humans; Ion Channel Gating; Pain; Peripheral Nervous System Diseases; Pyrimidines; Semicarbazones; Sodium Channel Blockers; Sodium Channels | 2007 |
Neramexane.
Topics: Alcoholism; Animals; Cyclopentanes; Humans; Neuroprotective Agents; Pain; Receptors, N-Methyl-D-Aspartate | 2002 |
3 trial(s) available for cyclopentane and Pain
| Article | Year |
|---|---|
Bilobalide, a unique constituent of Ginkgo biloba, inhibits inflammatory pain in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Capsaicin; Carrageenan; Cyclopentanes; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; Edema; Furans; Ginkgolides; Hindlimb; Hyperalgesia; Inflammation; Male; Pain; Pain Measurement; Pain Threshold; Rats; Rats, Wistar; Sensory System Agents; Vocalization, Animal | 2013 |
Antihyperalgesic and analgesic properties of the N-methyl-D-aspartate (NMDA) receptor antagonist neramexane in a human surrogate model of neurogenic hyperalgesia.
Topics: Aminopyridines; Analgesics; Capsaicin; Cross-Over Studies; Cyclopentanes; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Hyperalgesia; Injections, Intradermal; Nervous System Diseases; Pain; Physical Stimulation; Receptors, N-Methyl-D-Aspartate; Treatment Outcome | 2008 |
Clinical safety and efficacy of NG440: a novel combination of rho iso-alpha acids from hops, rosemary, and oleanolic acid for inflammatory conditions.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Cell Count; Blood Coagulation; Blood Pressure; Cells, Cultured; Cross-Over Studies; Cyclopentanes; Dinoprostone; Double-Blind Method; Drug Combinations; Feces; Female; Humans; Humulus; Kidney Function Tests; Leukocyte L1 Antigen Complex; Liver Function Tests; Male; Mice; Naproxen; Oleanolic Acid; Pain; Plant Extracts; Rheumatic Diseases; Rosmarinus | 2007 |
12 other study(ies) available for cyclopentane and Pain
| Article | Year |
|---|---|
Autophagy and cathepsin L are involved in the antinociceptive effect of DMBC in a mouse acetic acid-writhing model.
Topics: Acetic Acid; Analgesics; Animals; Autophagy; Benzylidene Compounds; Cathepsin L; Cyclopentanes; Disease Models, Animal; Epoxy Compounds; Female; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Pain; Pain Measurement; Pyridines; Signal Transduction | 2013 |
Intrathecal administration of sigma-1 receptor agonists facilitates nociception: involvement of a protein kinase C-dependent pathway.
Topics: Animals; Antitussive Agents; Calcium Signaling; Cyclopentanes; Disease Models, Animal; Enzyme Inhibitors; Ethylenediamines; Inflammation Mediators; Injections, Spinal; Male; Mice; Mice, Inbred ICR; Morpholines; Nociceptors; Pain; Pain Measurement; Pain Threshold; Posterior Horn Cells; Protein Kinase C; Proto-Oncogene Proteins c-fos; Receptors, sigma; Sigma-1 Receptor; Signal Transduction; Spinal Cord | 2008 |
Antinociceptive effects of chronic administration of uncompetitive NMDA receptor antagonists in a rat model of diabetic neuropathic pain.
Topics: Amines; Analgesics; Animals; Cyclohexanecarboxylic Acids; Cyclopentanes; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Gabapentin; gamma-Aminobutyric Acid; Male; Memantine; Pain; Pain Measurement; Physical Stimulation; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Streptozocin; Time Factors | 2009 |
Antinociceptive effects of methyl jasmonate in experimental animals.
Topics: Acetates; Acetic Acid; Analgesics; Animals; Cyclopentanes; Female; Formaldehyde; Male; Mice; Oxylipins; Pain; Rats; Rats, Sprague-Dawley | 2011 |
Estrogen destabilizes microtubules through an ion-conductivity-independent TRPV1 pathway.
Topics: Animals; Binding, Competitive; Cell Line; Cyclopentanes; Estradiol; Estrogens; Ganglia, Spinal; Gene Knockdown Techniques; Ion Channel Gating; Ligands; Male; Microtubules; Models, Molecular; Neurons; Pain; Phosphorylation; Protein Binding; Protein Kinase C-epsilon; Pseudopodia; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Signal Transduction; TRPV Cation Channels; Tubulin | 2011 |
Dexmedetomidine and clonidine inhibit the function of Na(v)1.7 independent of α(2)-adrenoceptor in adrenal chromaffin cells.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Binding Sites; Cattle; Cells, Cultured; Chromaffin Cells; Clonidine; Cyclopentanes; Dexmedetomidine; Imidazoles; Lidocaine; Organophosphorus Compounds; Ouabain; Pain; Receptors, Adrenergic, alpha-2; Scorpion Venoms; Sodium; Sodium Channels; Tetrodotoxin; Veratridine; Yohimbine | 2011 |
Novel cyclopentane dicarboxamide sodium channel blockers as a potential treatment for chronic pain.
Topics: Administration, Oral; Amides; Analgesics; Animals; Biphenyl Compounds; Cyclopentanes; Ion Channel Gating; Methylation; Mexiletine; Pain; Pain Measurement; Rats; Sodium Channel Blockers; Structure-Activity Relationship; Succinates; Sulfonamides | 2005 |
Structure-activity relationships of 1,5-biaryl pyrroles as EP1 receptor antagonists.
Topics: Analgesics; Animals; Benzoates; Biological Availability; Cyclohexanes; Cyclopentanes; Inflammation; Ligands; Pain; Pyrroles; Rats; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; Structure-Activity Relationship | 2006 |
The discovery of 6-[2-(5-chloro-2-{[(2,4-difluorophenyl)methyl]oxy}phenyl)-1-cyclopenten-1-yl]-2-pyridinecarboxylic acid, GW848687X, a potent and selective prostaglandin EP1 receptor antagonist for the treatment of inflammatory pain.
Topics: Alprostadil; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Cyclopentanes; Cytochrome P-450 Enzyme System; Dogs; Dose-Response Relationship, Drug; Freund's Adjuvant; Half-Life; Inflammation; Pain; Pyridines; Rats; Receptors, Prostaglandin E | 2007 |
Group II metabotropic glutamate receptor activation attenuates peripheral sensitization in inflammatory states.
Topics: Amino Acids; Animals; Behavior, Animal; Cyclopentanes; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Hot Temperature; Inflammation; Male; Nerve Fibers; Nociceptors; Pain; Peripheral Nerves; Physical Stimulation; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Skin; Xanthenes | 2008 |
Activation of the spinal sigma-1 receptor enhances NMDA-induced pain via PKC- and PKA-dependent phosphorylation of the NR1 subunit in mice.
Topics: Animals; Behavior, Animal; Blotting, Western; Cyclic AMP-Dependent Protein Kinases; Cyclopentanes; Disease Models, Animal; Dose-Response Relationship, Drug; Ethylenediamines; Immunohistochemistry; Injections, Spinal; Male; Mice; Mice, Inbred ICR; Morpholines; N-Methylaspartate; Pain; Pain Measurement; Phosphorylation; Posterior Horn Cells; Protein Kinase C; Receptors, N-Methyl-D-Aspartate; Receptors, sigma; Serine; Sigma-1 Receptor; Signal Processing, Computer-Assisted; Signal Transduction; Spinal Cord; Time Factors | 2008 |
Mrz 2/579, a fast kinetic NMDA channel blocker, reduces the development of morphine tolerance in awake rats.
Topics: Analgesics, Opioid; Animals; Cyclopentanes; Drug Tolerance; Male; Morphine; Neuroprotective Agents; Pain; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Sodium Chloride; Substance Withdrawal Syndrome; Wakefulness | 2001 |